Kalshi to offer betting on drug trial results and FDA regulatory decisions
Kalshi announced Thursday it will offer bets on drug trial results and FDA regulatory decisions, partnering with artificial intelligence firm AppliedXL. The platform said public contracts would surface trial information otherwise hidden by sponsors. CEO Tarek Mansour noted drug development is information-constrained, with critical data locked away from those.
How does this story land?
Summary by OZbrief Editorial · The Guardian Australia · Source
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 16 Jul 2026, 21:11 UTC · Updated 16 Jul 2026, 22:00 UTC
Summary by OZbrief Editorial. Original report: The Guardian Australia. Editorial policy · Corrections
Trending
- NDIS fails individuals needing substantial support, raising concerns over its effectiveness
- Australia's highest-paid chief executives revealed
- Fair Work Commission alters Sophie Mirabella’s caseload after police charges
- NSW government approves first pumped hydro project since Snowy 2.0
- Queensland Tribunal rules police watch house conditions violate children's rights
- Police fear ‘worst day care paedophile’ targeted remote Indigenous community